# Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

> **NCT05995600** · PHASE4 · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Antiphospholipid Syndrome
- Ischemic Stroke
- Transient Ischemic Attack
- Cerebrovascular Disease
- Cardiovascular Diseases
- Major Bleed

## Interventions

- **DRUG:** Antiplatelet Drug
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT05995600
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-20
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05995600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05995600, "Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05995600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*